BioSpace News Archive

OrthoGrid® Systems, Inc., a global medtech leader on a mission to digitally transform intraoperative musculoskeletal surgery, announces the publication of new clinical data supporting the use of its analog and digital technology in the Journal of Arthroplasty (JOA).

Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene and cell therapy, today announced that abstracts detailing new interim results from its ABO-102 Phase 1/2 Transpher A study for MPS IIIA and ABO-101 Phase 1/2 Transpher B study for MPS IIIB have been accepted for platform oral presentations during the late-breaking abstract session at the 17 th Annual WORLD Symposium ™ being held February 8-12, 2021. “Children

Concert Genetics today unveiled the Concert Genetics Benefit Program, an end-to-end genetic testing management solution that enables health plans to provide members with access to high-quality, clinically appropriate genetic testing while improving payment integrity and reducing manual work.

Abivax (Euronext Paris: FR0012333284 - ABVX), a clinical-stage biotechnology company harnessing the immune system to develop novel treatments for inflammatory diseases, viral diseases and cancer, today announced that Prof. Hartmut J. Ehrlich, M.D., CEO of Abivax, will present at the 39 th Annual J.P. Morgan Healthcare Conference on Thursday,

Heru, a Bascom Palmer Eye Institute medical technology company developing a next-generation AI platform for vision diagnostics and augmentation, announces its class I listing with the U.S. Food and Drug Administration for its cloud-based augmented/virtual reality platform’s first diagnostic application for Visual Field Exams.

The company and its CEO thank supporters and remain fully committed; company will also provide a series of GenViro! test results it has amassed demonstrating the technologys promise

LeAnn Affholter, Vice President of People, and Carla Pagotto, Vice President of Marketing, join Cardiac Insight’s team to support growth and accelerate market adoption

Eargo, Inc. (Nasdaq: EAR), a medical device company on a mission to improve the quality of life for people with hearing loss, today announced it will present at the 39 th Annual J.P. Morgan Healthcare Conference via web cast. Christian Gormsen, Eargo’s President and Chief Executive Officer, is scheduled to present on Tuesday, January 12 th at 2:00pm Eastern Time. The live web cast of Eargo’s presentation, along with accompanying slides, c

electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that it has entered into an agreement with Pro Medical Baltic UAB (“PMB”), whereby PMB will serve as the exclusive distributor of gammaCore Sapphire™ non-invasive vagus nerve stimulation (“nVNS”) to patients suffering from primary headache disorders in Lithuania, Latvia, Belarus, Kazakhstan and Ukraine. “We are delighted to partner with Pro Me

CooperCompanies, will present virtually at the J.P. Morgan Healthcare Conference on January 12, 2021. Al White, President and CEO, will represent the Company in a presentation scheduled to begin at 12:40PM PT.